Matthew A Triplette MD MPH
Critical Care Medicine, Pleural Disease
Resident Physician, Medicine, UCSF School of Medicine
Join to View Full Profile
1959 NE Pacific StSeattle, WA 98195
Phone+1 206-598-3300
Dr. Triplette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pulmonary Disease and Critical Care Medicine, 2014 - 2017
University of North Carolina at Chapel Hill School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2013 - Present
WA State Medical License 2014 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 1 citationsA Multistakeholder Qualitative Study to Inform Sexual Orientation and Gender Identity Data Collection in the Cancer Care Setting.Matthew Triplette, Nicholas Giustini, Nicolas Anderson, Tiffany Go, N F N Scout
LGBT Health. 2025-04-01 - Adherence to Follow-Up Lung Cancer Screening-A Critical Target for Intervention.Francesca C Duncan, Matthew Triplette
JAMA Network Open. 2025-03-03 - Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement.Louise M Henderson, Roger Y Kim, Nichole T Tanner, Emily B Tsai, Abbie Begnaud
American Journal of Respiratory and Critical Care Medicine. 2025-03-01
Journal Articles
- Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesSarah T Arron, Isaac Brownell, Matthew A Triplette, Eric A Engels, JAMA Dermatology
Authored Content
- Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesMay 2020
- Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesMay 2020
Press Mentions
Annual Lung Cancer Screening Adherence Drops After Initial Exam, Underlining Need for InterventionMarch 19th, 2025- Tip Sheet: BRCA Cancer Risks for Men, a New Way to Classify Brain Tumors, Funding for Bile Duct Cancer — and Cancer Care in LGBTQ+ CommunitiesAugust 7th, 2024
- Almost Half of Patients with High-Risk Results Delay Follow-up Care for Lung CancerMay 18th, 2022
- Join now to see all
Grant Support
- Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized SettingsFRED HUTCHINSON CANCER CENTER2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
